Radius Health

company

About

Radius Health develops drug therapies for osteoporosis and women’s health.

  • 251 - 500

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$43M
Industries
Biotechnology,Health Care,Health Diagnostics,Pharmaceutical,Women's
Founded date
Nov 1, 2003
Number Of Employee
251 - 500
Operating Status
Active

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health.

The company's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life.

Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging.

Radius's scientific leadership includes some of the world's leading researchers in the fields of bone metabolism, endocrinology, and medicinal chemistry, and the company has a broad foundation in nuclear hormone receptors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$68M
Radius Health has raised a total of $68M in funding over 2 rounds. Their latest funding was raised on Apr 25, 2013 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 25, 2013 Private Equity(PE) $43M 1 Detail
Nov 20, 2008 Series C $15M 1 MPM Bio IV NVS Strategic Fund Detail
Sep 17, 2007 Series C $10M 1 MPM Bio IV NVS Strategic Fund Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Radius Health has made 2 investments. Their most recent investment was on Oct 30, 2018, when GoHenry raised £6.28M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 30, 2018 GoHenry
Equity Crowdfunding £6.28M Children
Oct 4, 2017 Seedrs
Equity Crowdfunding £6M Crowdfunding

Investors

Number of Lead Investors
Number of Investors
2
1
Radius Health is funded by 1 investors. MPM Bio IV NVS Strategic Fund are the most recent investors.
Investor Name Lead Investor Funding Round
MPM Bio IV NVS Strategic Fund Private Equity(PE)